SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-028666
Filing Date
2023-10-20
Accepted
2023-10-20 14:19:02
Documents
15
Period of Report
2023-10-20
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ctdh20231020_8k.htm   iXBRL 8-K 31174
2 EXHIBIT 4.1 ex_583733.htm EX-4.1 59381
3 EXHIBIT 10.1 ex_583734.htm EX-10.1 127729
  Complete submission text file 0001437749-23-028666.txt   405668

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ctdh-20231020.xsd EX-101.SCH 3892
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctdh-20231020_def.xml EX-101.DEF 13444
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctdh-20231020_lab.xml EX-101.LAB 17671
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctdh-20231020_pre.xml EX-101.PRE 13421
9 EXTRACTED XBRL INSTANCE DOCUMENT ctdh20231020_8k_htm.xml XML 4406
Mailing Address PO BOX 1180 ALACHUA FL 32616-1180
Business Address 6714 NW 16TH STREET, SUITE B GAINESVILLE FL 32653 386-418-8060
Cyclo Therapeutics, Inc. (Filer) CIK: 0000922247 (see all company filings)

IRS No.: 593029743 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39780 | Film No.: 231336877
SIC: 2836 Biological Products, (No Diagnostic Substances)